Tetragon Financial Group
Based on Q4 2025 SEC Form 13F filings, Tetragon Financial Group manages a portfolio with 28 disclosed long equity positions. The fund's 13F market value sits at $0.50B, reflecting a decline in quarter-over-quarter AUM. Ranked by portfolio weight, the top holdings are UIPATH INC (PATH) at 60.30%, KOLIBRI GLOBAL ENERGY INC (KGEI) at 5.75%, and LYFT INC (LYFT) at 4.08%. The fund is primarily focused on the Technology sector. New positions this quarter include PRAXIS PRECISION MEDICINES, INC. (PRAX) , RAPT THERAPEUTICS INC (SYN_75382E208) , AGIOS PHARMACEUTICALS INC (AGIO) , HARMONY BIOSCIENCES HLDGS IN (HRMY) , and NEKTAR THERAPEUTICS (NKTR) . Fully exited positions include ALIBABA GROUP HLDG LTD (SYN_01609WBG6) , LITHIUM ARGENTINA AG (SYN_53680QAA6) , CABLE ONE INC (SYN_12685JAE5) , PROGRESS SOFTWARE CORP (SYN_743312AB6) , and OATLY GROUP AB (SYN_67421JAC2) . Ranked by the share of each peer fund's 13F equity portfolio that overlaps with Tetragon Financial Group's disclosed positions as of Q4 2025, the closest peers are Commodore Capital (19.8%), Deep Track (17.5%), and Exome Asset Management (14.2% overlap).
- 13F AUM
- $0.5B
- Equity Positions
- 28
- Top-10 Concentration
- 86.8%
- Largest Sector · 71.2%
- Technology
- Longest held · 31 qtrs
- AUTL
- Median Holding Period
- 3 Qtrs
Top 10 HoldingsQ4 2025
Ranked by portfolio weight. Δ QoQ is the change in weight versus the previous reporting quarter.
| # | Ticker | Company | Sector | Shares | Weight | Δ QoQ | Market Value |
|---|---|---|---|---|---|---|---|
| 1 | PATH | Technology | 17,450,000 | 60.30% | +27.37% | $286.0M | |
| 2 | KGEI | Energy | 6,934,504 | 5.75% | +0.06% | $27.3M | |
| 3 | LYFT | Technology | 1,000,000 | 4.08% | +0.89% | $19.4M | |
| 4 | AUTL | Healthcare | 9,500,000 | 3.99% | +1.74% | $18.9M | |
| 5 | CXM | Technology | 2,200,000 | 3.61% | +1.14% | $17.1M | |
| 6 | WK | Technology | 150,000 | 2.73% | +0.85% | $12.9M | |
| 7 | ANNX | Healthcare | 2,032,455 | 2.15% | +1.22% | $10.2M | |
| 8 | PRAX | Healthcare | 22,952 | 1.43% | — | $6.8M | |
| 9 | CLDX | Healthcare | 243,800 | 1.40% | +0.26% | $6.6M | |
| 10 | ARWR | Healthcare | 96,935 | 1.36% | +0.95% | $6.4M |
Quarterly shiftsvs previous quarter
Top movers in Tetragon Financial Group's Form 13F versus the prior reporting quarter. Δ Weight is the change in portfolio weight (percentage points); Δ Shares is the percent change in share count.
| Company | Ticker | Δ Weight | Δ Shares |
|---|---|---|---|
| UIPATH INC | PATH | +27.37% | +2.95% |
| AUTOLUS THERAPEUTICS PLC | AUTL | +1.74% | +0.00% |
| ANNEXON INC | ANNX | +1.22% | -3.79% |
| SPRINKLR INC | CXM | +1.14% | +0.00% |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | +0.95% | +18.44% |
No notable decreases.
| Company | Ticker | New weight |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC.NEW | PRAX | 1.43% |
| RAPT THERAPEUTICS INCNEW | SYN_75382E208 | 0.94% |
| AGIOS PHARMACEUTICALS INCNEW | AGIO | 0.93% |
| HARMONY BIOSCIENCES HLDGS INNEW | HRMY | 0.65% |
| NEKTAR THERAPEUTICSNEW | NKTR | 0.62% |
| Company | Ticker | Prev weight |
|---|---|---|
| ALIBABA GROUP HLDG LTD | SYN_01609WBG6 | 25.39% |
| LITHIUM ARGENTINA AG | SYN_53680QAA6 | 3.57% |
| CABLE ONE INC | SYN_12685JAE5 | 3.02% |
| PROGRESS SOFTWARE CORP | SYN_743312AB6 | 2.99% |
| OATLY GROUP AB | SYN_67421JAC2 | 2.67% |
Portfolio composition
Sectors, concentrations, and a tap-through treemap of every position in the fund's latest 13F.
Quarterly shifts
Top movers versus the prior reporting quarter. Left panel bridges market-value change in USD millions; right panel shows share-count change in %.
Holding period analytics
Distribution of holding periods for all 592 stocks the fund has ever held (up to selected quarter):
Peer Group — Funds With Most Portfolio Overlap
Ranked by percentage of the peer fund's 13F equity portfolio that overlaps with Tetragon Financial Group's positions in Q4 2025.
| # | Fund | Shared Positions | Overlap % |
|---|---|---|---|
| 1 | Commodore Capital | 5 | 19.8% |
| 2 | Deep Track | 7 | 17.5% |
| 3 | Exome Asset Management | 5 | 14.2% |
| 4 | Altimeter | 1 | 6.7% |
| 5 | Irenic | 1 | 6.2% |
13F AUM Development
Quarterly 13F-reported equity AUM for Tetragon Financial Group, derived from aggregate long equity position market values disclosed to the U.S. SEC.
Methodology & FAQ
How We Track Tetragon Financial Group Holdings
Our data is systematically aggregated directly from quarterly Form 13F-HR disclosures submitted to the U.S. Securities and Exchange Commission (SEC).
- Who Must File (Reporting Threshold): This dataset includes filings from U.S. institutional investment managers, hedge funds, mutual funds, university endowments, and family offices managing at least $100 million in qualifying discretionary U.S. equities.
- What is Included (Data Scope): We exclusively capture long equity positions and listed options (calls and puts) for Tetragon Financial Group. By SEC regulation, 13F filings do not require the disclosure of short positions, non-U.S. holdings, or OTC derivatives.
- Portfolio Weight Explained (Metric Definition): “Portfolio Weight” shows how much of a fund's total 13F U.S. equity portfolio is allocated to a specific position on the reporting date.
- How to Use This Data (Interpretation): Quarter-over-quarter changes in shares and portfolio weight reflect a combination of active trading and market price movements. These are descriptive metrics of fund allocation, not explicit buy or sell signals.
How do you measure hedge fund conviction in Tetragon Financial Group's portfolio?
We evaluate conviction by looking at portfolio weight rather than just absolute share count. A position that represents a large percentage of a fund's total 13F equity value signals high conviction, regardless of whether it ranks highly in absolute dollar terms. Tracking how this weight changes quarter-over-quarter helps distinguish active capital allocation from passive drift.
Does Tetragon Financial Group's 13F data include short positions or derivatives?
SEC Form 13F only mandates the disclosure of long U.S. equity positions and listed options (put and call contracts). Short interest, swaps, and OTC derivatives are excluded by regulatory design. To ensure accurate position scaling, listed options are reported based on their underlying share equivalent.
Are family offices and endowments included in this data?
Yes. Any institutional entity exercising investment discretion over at least $100 million in qualifying U.S. equities must file a Form 13F — this explicitly includes single-family offices and university endowments. If a qualifying entity holds positions reported by Tetragon Financial Group, their allocation is included in this dataset.
When is the data updated, and is there a reporting lag?
Institutional investment managers are required to file their Form 13F within 45 days after the end of each calendar quarter (the standard “T+45” window). Our platform processes filings immediately upon publication to the SEC EDGAR database, providing point-in-time consensus positioning without look-ahead bias.
Data Source: Aggregated from public SEC Form 13F filings via the EDGAR database.